Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kuentz

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 28, 2007
[ABO incompatibility and non myeloablative allogeneic stem cell transplantation]J-V Malfuson, Y Hicheri, P Bonin, et al.
Leukemia|February 1, 1990
Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemiaJ M Pignon, T Henni, S Amselem, et al.
Journal of the American Academy of Dermatology|January 1, 1992
Sclerodermatous chronic graft-versus-host disease. Analysis of seven casesO Chosidow, M Bagot, J P Vernant, et al.
British Journal of Cancer|June 1, 1986
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's diseaseT Philip, J Dumont, F Teillet, et al.
British Journal of Haematology|May 8, 1999
Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaM Diviné, D Boutolleau, M H Delfau-Larue, et al.
Blood|January 1, 1994
Thrombocytopenia after bone marrow transplantation caused by a recipient origin Br(a) allo-antibody: presence of mixed chimerism 3 years after the graft without hematologic relapseP Bierling, J M Pignon, M Kuentz, et al.
Vox Sanguinis|December 22, 2006
Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantationJ-V Malfuson, R B Amor, P Bonin, et al.
Cancer|January 1, 1985
Acute promyelocytic leukemia in 57 previously untreated patientsC Cordonnier, J P Vernant, B Brun, et al.
Transplantation|November 14, 1997
Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignanciesS Lachance, S Le Gouvello, F Roudot, et al.
Bone Marrow Transplantation|February 19, 2002
Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised studyC Fortanier, M Kuentz, L Sutton, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 28, 2007
[ABO incompatibility and non myeloablative allogeneic stem cell transplantation]J-V Malfuson, Y Hicheri, P Bonin, et al.
Leukemia|February 1, 1990
Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemiaJ M Pignon, T Henni, S Amselem, et al.
Journal of the American Academy of Dermatology|January 1, 1992
Sclerodermatous chronic graft-versus-host disease. Analysis of seven casesO Chosidow, M Bagot, J P Vernant, et al.
British Journal of Cancer|June 1, 1986
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's diseaseT Philip, J Dumont, F Teillet, et al.
British Journal of Haematology|May 8, 1999
Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaM Diviné, D Boutolleau, M H Delfau-Larue, et al.
Blood|January 1, 1994
Thrombocytopenia after bone marrow transplantation caused by a recipient origin Br(a) allo-antibody: presence of mixed chimerism 3 years after the graft without hematologic relapseP Bierling, J M Pignon, M Kuentz, et al.
Vox Sanguinis|December 22, 2006
Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantationJ-V Malfuson, R B Amor, P Bonin, et al.
Cancer|January 1, 1985
Acute promyelocytic leukemia in 57 previously untreated patientsC Cordonnier, J P Vernant, B Brun, et al.
Transplantation|November 14, 1997
Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignanciesS Lachance, S Le Gouvello, F Roudot, et al.
Bone Marrow Transplantation|February 19, 2002
Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised studyC Fortanier, M Kuentz, L Sutton, et al.
Pageof 10